Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abbott Abbokinase Relaunches With Limited Indication, Without Bold Warning

Oct 14 2002

• By The Pink Sheet

Related Content

Abbott Will Outlicense Ketolide Antibiotic, Focus On Quinolone And D2E7

Jul 15 2002

Abbott Abbokinase "Dear Doctor" Letter Draws Warning From FDA

Mar 29 1999

Abbott Projects Synthroid Double-Digit Growth Despite Early-2002 Phase-Down

Jan 21 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window